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Abstract: Thisreview highlighted thefollowing:(i)pathogenicmechanismofthethermostable
direct hemolysin produced by Vibrio parahaemolyticus, especially on its cardiotoxicity, (ii) heat-labile
and heat-stable enterotoxins produced by enterotoxigenic Escherichia coli, especially structure–
activity relationship of heat-stable enterotoxin, (iii) RNA N-glycosidase activity of Vero toxins (VT1
and VT2) produced by enterohemorrhagic Escherichia coli O157:H7, (iv) discovery of Vibrio cholerae
O139, (v) isolation of new variant of Vibrio cholerae O1 El Tor that carries classical ctxB, and
production of high concentration of cholera toxin by these strains, and (vi) conversion of viable but
nonculturable (VBNC) Vibrio cholerae to culturable state by co-culture with eukaryotic cells.
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N-glycosidase activity of Vero toxins, Vibrio cholerae O139, Viable but nonculturable (VBNC)
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Introduction
My scientiﬁc career was initiated in 1961 as a
student of Dr. Tsunesaburo Fujino, Professor of
Bacteriology and Serology, Research Institute for
Microbial Diseases, Osaka University, who discov-
ered Vibrio parahaemolyticus. During last 50 years,
I have worked on enteric pathogens such as Vibrio
parahaemolyticus, enterotoxigenic Escherichia coli,
enterohemorrhagic E. coli and Vibrio cholerae.I n
this article I will summarize what my colleagues and
myself have accomplished on these enteric pathogens.
Some background to understand why I have worked
on the speciﬁc topics will also be discussed.
Vibrio parahaemolyticus
In 1950, Fujino et al.1) discovered Vibrio para-
haemolyticus as a causative bacterium of a case of
food poisoning occurred in Osaka, Japan. It is one of
the most important causative agents of bacterial food
poisoning. In epidemiological studies on V. para-
haemolyticus, Kato et al.2) found that strains isolated
from patients caused hemolysis on special blood agar.
The agent to cause the hemolysis was identiﬁed to be
thermostable direct hemolysin (TDH).3)
To study the pathogenesis of TDH, we ﬁrst
puriﬁed TDH from a strain isolated from a patient.4)
The puriﬁed TDH is composed of two subunits
of 21K dalton5) and is not inactivated by heating
at 100°C for 10 minutes. It shows various biological
activities such as hemolytic activity, cytotoxic
activity on various cultured cells, enterotoxicity in
rabbit ileal loops and lethal toxicity in mice and rats.
We demonstrated that the lethal toxicity of
the puriﬁed TDH was due to its cardiotoxicity.6)
This was ﬁrst suggested by a rapid death of mice and
rats after intravenous injection of TDH. As shown in
Table 1, more than 5µg of TDH killed mice within
1 minute after intravenous injection. Even 1µg of
TDH killed mice within 10 minutes. Several bacterial
toxins, such as streptolysin O, tetanolysin, hemolysin
of Listeria monocytogenes, caused rapid death of
animals on intravenous injection and it was demon-
strated that they showed cardiotoxicity. Thus, we
attempted to demonstrate the cardiotoxicity of TDH.
When ventricular tissue from the hearts of 14–16
days old mouse fetuses were cultured in Eagle’s
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fetal bovine serum at 36°C under an atmosphere of
5% CO2 and 95% air, the cells beat spontaneously
and regularly. When 1–1.5 × 106 cells were seeded
into dishes, a large cluster of 2–4mm in diameter
containing more than 105 cells was obtained after
cultivation for 1 day. All the myocardial cells in cell
cluster beat synchronously and regularly at 100–
180beats/minute and this rate was maintained for at
least 24 hours.
Figure 1 shows the eﬀect of TDH on the beating
of a cell cluster of cultured myocardial cells.6) On
addition of 0.05µg/ml of TDH to the medium the
beating increased slightly, but it returned to normal
within 10 minutes (Fig. 1A). On addition of 0.1µg of
TDH, the beating was ﬁrst rapidly stimulated and
then stopped suddenly within one minute. Then,
six minutes after the addition of TDH, the beating
suddenly started again at the normal rate and
remained unchanged during further observation
(Fig. 1B). Similarly on addition of 0.2µg of TDH,
the beating at ﬁrst increased, then stopped and then
started again (Fig. 1C), but interval between the
time of stopping and of starting again was longer
than that on addition of 0.1µg of TDH. On addition
of 1µg or more of TDH per ml of medium, the beating
also ﬁrst increased and then stopped abruptly,
and then almost all the cells rapidly disintegrated
(Fig. 1D).
To study further the various kinds of biological
activities of TDH on various kinds of cells, such as
hemolysis on erythrocytes and cardiotoxicity on
myocardial cells, attempts to determine the mem-
brane receptor for TDH was carried out. Figure 2
shows the result of such an experiment.7) When TDH
was preincubated with GT1 and GD1a gangliosides,
its hemolytic activity was lost, whereas when it was
preincubated with GM1 and GM2 gangliosides its
hemolytic activity did not decrease. Treatment of
ganglioside GT1 and GD1a with neuraminidase
abolished their inhibitory eﬀects on the hemolytic
activity of TDH. It is known that TDH caused
Table 1. Lethal activity of TDH on intravenous injection into
mice (from Ref. 6)
Amount of TDH injected
(µg of protein per mouse)
Survival time after injection
(mean ± S.D.)
10.0 35.5 ± 4.8sec.
5.0 49.0 ± 8.4
2.5 561.2 ± 368.8
1.0 1121.5 ± 291.0
0.5 no death
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Fig. 1. Eﬀect of TDH on the beating of a cell cluster of cultured
myocardial cells (from Ref. 6). Mouse heart cells were cultured
and the amounts of TDH indicated below were added to the
medium at zero time. The beating of the cell clusters was
expressed as a percentage of that observed in the absence of
TDH. The concentrations of TDH were: (A) 0.05µg/ml, (B)
0.1µg/ml, (C) 0.2µg/ml and (D) 1µg/ml. ( ) normal beating,
( ) weaker beating, ( ) no beating but no cell disintegration,
( ) cell disintegration.
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Fig. 2. Eﬀect of various gangliosides on the hemolytic activity of
TDH (from Ref. 7). The indicated amounts of various ganglio-
sides were mixed with 5µg (0.12nmol) of TDH in 0.01M Tris–
HCl buﬀer (pH 7.2) in a volume of 0.125ml and incubated at
37°C for 30min. Hemolytic activity was assayed after further
incubation at 37°C for 30min by measuring the absorbance at
540nm. ( )G T1,( )G D1,( )G M1,( )G M2.
Y. TAKEDA [Vol. 87, 2hemolysis of human erythrocytes, but not of horse
erythrocytes. The absence of GT1 and GD1a ganglio-
sides on horse erythrocytes well explained the above
results.
Diarheagenic Escherichia coli
Escherichia coli is a commensal bacterium in
human large intestine. However, several kinds of
diarheagenic E. coli that cause diarrhea in humans
have been reported. They are enteropathogenic E.
coli (EPEC), enteroinvasive E. coli (EIEC), entero-
toxigenic E. coli (ETEC), enterohemorrhagic E. coli
(EHEC) and enteroaggregative E. coli (EAgEC).
Each of them causes diarrhea in human by diﬀerent
mechanisms. Among these ﬁve diﬀerent kinds of
diarrheagenic E. coli, diseases caused by ETEC and
EHEC are known to be toxin-mediated. In this
section, I will discuss on the toxins produced by
ETEC and EHEC and the diseases caused by these
diarrheagenic E. coli.
(i) ETEC. ETEC was ﬁrst reported in 1956 by
De in India.8) He found that E. coli strain isolated
from stool of cholera-like patient gave a similar
positive reaction in the ileal loop test as V. cholerae
did. Later in 1971, Sack et al.9) demonstrated a
protein toxin in the culture supernatant of ETEC,
which is currently known as heat-labile enterotoxin
(LT).
The importance of ETEC is highlighted in 1976
when Merson et al.10) reported that ETEC is a major
enteropathogen that cause traveller’s diarrhea. In our
country, we reported that ETEC was isolated from
about 40% of diarrheal patients who just came back
to Osaka (Itami) International Airport from South-
East Asian countries.11)
Smith and Gyles12) reported that ETEC produc-
es heat-stable enterotoxin (ST) in addition to LT
already reported by Sack et al.9) LT is a protein toxin
inactivated by heating at 60°C for 10 minutes while
ST is a peptide toxin not inactivated by heating even
100°C for 10 minutes.
Among many reports that attempted to purify
LT, the most successful one is that reported by
Clements and Finkelstein.13) Their method is quite
unique: they found that LT was absorbed by Agarose
A5m gel and was eluted out by a buﬀer containing
0.2M galactose. Applying their method to purify LT
we found that there are two immunologically distinct
LTs.14) One is LT from ETEC isolated from human
patient (LTh) and the other is that from porcine
stool (LTp). At that time, it was known that LT is
cross-reactive with cholera toxin (CT) produced by
V. cholerae. We examined the immunological rela-
tionship among these three enterotoxins, LTh, LTp
and CT, and found that they are immunologically
related but not identical.15) Several other investiga-
tors conﬁrmed our ﬁnding by nucleotide sequence
analysis of the genes encoding LTh, LTp and CT.
Regarding ST, we puriﬁed ST in collaboration
with Dr. Yasutsugu Shimonishi and his colleagues of
Protein Institute of Osaka University. Like LT, we
found that there are two diﬀerent kinds of ST, that is
one from human patient (STh) and the other from
porcine stool (STp). It was found that STh consisted
of 19 amino acids,16) while STp consisted of 18 amino
acids.17) As shown in Table 2, primary structure of
both STs is quite similar but is diﬀer in some amino
acids.
To study a structure–activity relationship of
STs, we tried chemical synthesis of mature STs as
well as their short analogues.18),19) It was found
that chemically synthesized STh and STp showed
the similar biological activity to those produced by
ETEC in suckling mouse assay (accumulation of ﬂuid
in intestine). Moreover, as shown in Table 3, short
analogues of both STh and STp, which have less
numbers of amino acids at their N-terminus as well as
C-terminus, showed positive reaction in the suckling
mouse assay, thus was concluded that a peptide
consist of 13 amino acids was a core to show the
biological activity.20)
(ii) EHEC. EHEC is deﬁned by its ability to
produce Vero toxin (VT) that is cytotoxic to Vero
cells. The ﬁrst outbreak of food poisoning caused by
EHEC was reported in 1982 in the US. In this
outbreak, Riley et al.21) isolated an E. coli O157:H7
strain as a new kind of bacteria to cause diarrhea.
Symptoms associated with this organism were quite
severe with abdominal cramps and bloody diarrhea,
which was named as hemorrhagic colitis. O’Brien
et al.22) found that E. coli O157:H7 reported by Riley
et al.21) produced VT and the cytotoxic activity was
Table 2. Primary structure of STh and STp (from Refs. 16, 17)
STh: Asn-Ser-Ser-Asn-Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys-Tyr
STp: Asn-Thr-Phe-Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Ala-Gly-Cys-Tyr
Enteric bacteria No. 1] 3neutralized by an antitoxin to Shiga toxin produced
by Shigella dysenteriae type 1. This ﬁnding was quite
unique at that time as the toxins produced by two
diﬀerent bacterial species were immunologically
related each other. It is because of this related
characteristic that EHEC is also called Shiga-toxin
producing E. coli (STEC).
There are two types of VT, namely VT1 and
VT2. VT1 was ﬁrst reported by Konowalchuk23) in
1977 and several years later conﬁrmed by others.24),25)
On the other hand, VT2 that was immunological
related but diﬀerent to VT1 was isolated for the ﬁrst
time in 1986 from a patient admitted to an Infectious
Disease Hospital in Tokyo.26) Almost the same time,
Scotland et al.27) and Strockbine et al.28) reported the
existence of VT2.
Several investigators including our group puri-
ﬁed both VT129) and VT2.30) Although both VTs
have the similar biological activities, VT2 was
more potent than VT1. Both VT1 and VT2 consist
of two subunits: one molecule of A subunit and ﬁve
molecules of B subunit. The A subunit has an
enzymatic activity as described below and the B
subunit binds to the receptor molecule of cell surface.
Many investigators reported the primary structure of
both VTs. We determined by both amino acid and
nucleotide sequencing that the primary structure of
VT1 is exactly the same to that of Shiga toxin.31)
Regarding the molecular mode of action of Shiga
toxin, it has been known that Shiga toxin inhibits
protein synthesis in eukaryotic cells by inhibiting
elongation factor 1 (EF-1)-dependent aminoacyl-
tRNA binding to 60S ribosomal subunits.32) We
demonstrated that not only VT1 but also VT2
inactivated 60S ribosomal subunits and inhibited EF-
1-dependent aminoacyl-tRNA binding in eukaryotic
cells.33),34) To elucidate further the mode of action
of VTs, we studied in conjunction with the results
obtained on the mode of action of a plant rectin,
ricin. Endo and his coworkers35),36) demonstrated
that ricin showed RNA N-glycosidase activity and
cleaved N-glycosidic bond of an adenosine at position
4,324 from the 5′ terminus of the 28S ribosomal RNA
of 60S ribosomal subunits of eukaryotic cells, which
caused the inhibition of protein synthesis. Having
recognized that the mode of action of Shiga toxin was
similar to that of ricin, we demonstrated that Shiga
toxin and VT2 exhibited an RNA N-glycodidase
activity and cleaved the N-glycosidic bond of the
adenosine residue, as shown in Fig. 3, at position
4,324 from the 5′ terminus of the 28S ribosomal RNA
of 60S ribosomal subunit of rabbit reticulocytes
(Fig. 3).37)
Since the molecular modes of action of Shiga
toxin and VTs were found to be exactly the same as
that of ricin, the amino acid sequences of the A
Table 3. Biological activity of chemically synthesized STh, STp and their analogues (from Ref. 20)
Amino acid sequence
Minimum eﬀective dose
(ng/100µl)
Asn-Ser-Ser-Asn-Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys-Tyr STh(1–19) 0.8
Asn-Ser-Ser-Asn-Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys STh(1–18) 0.4
Ser-Ser-Asn-Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys-Tyr STh(2–19) 0.8
Ser-Asn-Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys-Tyr STh(3–19) 1.3
Asn-Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys-Tyr STh(4–19) 1.1
Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys-Tyr STh(5–19) 0.8
Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys STh(5–18) 0.5
Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys-Tyr STh(6–19) 0.6
Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys STh(6–18) 0.6
Asn-Thr-Phe-Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Ala-Gly-Cys-Tyr STp(1–18) 1.0
Asn-Thr-Phe-Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Ala-Gly-Cys STp(1–17) 1.3
Thr-Phe-Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Ala-Gly-Cys-Tyr STp(2–18) 0.5–2.0
Phe-Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Ala-Gly-Cys-Tyr STp(3–18) 1.5–2.0
Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Ala-Gly-Cys-Tyr STp(4–18) 0.8–1.0
Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Ala-Gly-Cys STp(4–17) 1.2
Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Ala-Gly-Cys-Tyr STp(5–18) 0.8–1.0
Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Ala-Gly-Cys STp(5–17) 0.7
Y. TAKEDA [Vol. 87, 4subunit of VT1, VT2 and ricin were compared to
determine sequence homology(s). Three regions of
the homology containing conserved (identical or
chemically similar) amino acid residues were identi-
ﬁed. By site-directed mutagenesis of the targeted
gene to encode a speciﬁc amino acid, we constructed
several mutant genes that encoded mutant VT1 with
a single amino acid replacement in each of the three
regions described above. It was found that among
many mutant VT1s, two mutants that had the
replacement of Glu 167 by glutamine (E167Q) and of
Arg 170 by leucine (R170L) showed signiﬁcantly
reduced toxicity.38) The mutant VT1s were puriﬁed
and their activities were examined. As shown in
Table 4, both cytotoxic activity to Vero cells and
inhibitory activity of protein synthesis in rabbit
reticulocyte lysate were markedly decreased in the
puriﬁed E167Q.39) It was demonstrated that the
mutant VT1, E167Q, possessed similar antigenicities
to that of wild type VT1, suggesting that the mutant
VT1, E167Q, may be used as a candidate toxoid to
protect VT1-mediated disease.
Vibrio cholerae
V. cholerae is classiﬁed into two biotypes,
namely classical and El Tor. The classiﬁcation is
based on several phenotypes, such as susceptibility
to polymixin B, chicken erythrocytes agglutina-
tion, hemolysis of sheep erythrocytes and Voges–
Proskauer test which measures the production of
acetylmethylcarbinol, and phage susceptibilities.
The organisms of each biotype are further classiﬁed
into serogroups on the basis of variations in the
cell surface lipopolysaccharide (O antigen) More
than 200 serogroups are so far idenitiﬁed. Moreover,
both classical and El Tor biotypes show three diﬀer-
ent serotypes, namely Ogawa, Inaba and Hikojima.
A summary of the classiﬁcation is as shown in
Fig. 4.
(i) Discovery of V. cholerae O139. Until
1992, it was known that only O1 serogroup of V.
cholerae strain was associated with epidemic and
pandemic cholera, and that strains which did not
agglutinate with the O1 antiserum (collectively
called non-O1 V. cholerae) were widely distributed
in the aquatic environment and were responsible for
sporadic cases of gastroenteritis.
In November 1992, non-O1 V. cholerae strains
were isolated from patients of cholera-like disease in
Chennai (then Madras), India where a large explosive
outbreak of the disease occurred. Almost concur-
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Fig. 3. RNA N-glycosidase activity of VT1 (Shiga toxin), VT2 and ricin (from Ref. 37).
Table 4. Comparison of biological activities of the puriﬁed
mutant VT1s and wild-type VT1 (from Ref. 38)
Toxin
Cytotoxic
activity
CD50 (µg)
Mouse
lethality
LD50 (µg)
Inhibition of
protein synthesis
ED50 (µg)
E167Q 30 80 >100
R170L 9 10 2
Wild-type 0.0001 0.04 0.008
Enteric bacteria No. 1] 5rently, an unexplained shift from the previously
dominant O1 serogroup to the non-O1 sergroup
occurred in the isolation rates of V. cholerae from
cholera patients admitted to the Infectious Diseases
Hospital in Kolkata (then Calcutta). This was
followed by a large outbreak of clinical cholera due
to the non-O1 strains of V. cholerae in the southern
coastal belt of Bangladesh between December 1992
and January 1993.40),41)
We carried out an extensive characterization of
the isolated non-O1 strains and found that all the
non-O1 strains of V. cholerae having the following
unusual properties: (i) all the strains did not
agglutinate with polyvalent O1 antiserum or with
monoclonal antibodies against factors A, B and C of
the O1 serogroup that are the determinant factors of
Ogawa, Inaba and Hikojima serotypes; (ii) all the
strains did not agglutinate with antisera against any
of the existing 137 serogroups of V. cholerae non-O1
recognized at that time; (iii) all the strains produced
cholera toxin, which is unusual for the strains of the
non-O1 serogroups.
Serological studies revealed that the non-O1
outbreak strains from India and Bangladesh were
similar and distinct from the existing 138 serogroups
of V. cholerae; consequently these strains were
assigned to a new serogroup, namely O139 and given
a synonym “Bengal” to symbolize the ﬁrst isolation of
these strains from coastal areas located on the Bay of
Bengal.42)
On investigation, the clinical features of the
disease caused by the O139 V. cholerae were found
to be indistinguishable from those of cholera caused
by the O1 V. cholerae.43) Cholera working group,
International Centre for Diarrhoeal Diseases Re-
search, Bangladesh44) reported similar ﬁndings with
patients in Bangladesh. Based on these ﬁndings we
designated the disease caused by V. cholerae O139
as cholera.43) WHO promptly responded to these
reports and designated the disease caused by V.
cholerae O139 as cholera.45)
V. cholerae O139 spreads rapidly in India46) and
Bangladesh, and to several Asian countries; ﬁrst
isolated in Thailand47) and then in Nepal, Pakistan,
Malaysia and China. Imported cases were also
reported from several countries worldwide including
Japan.
Initially it was predicted that V. cholerae O139
might spread all over the world and the eighth
pandemic of cholera might be recoded, but the spread
was restricted in the Indian subcontinent. Moreover,
the isolation of O139 strains from cholera patients
was so limited that the isolation rate in Kolkata these
days has been less than 1%.48)
(ii) Emergence of V. cholerae El Tor variant
and its cholera toxin production. In two biotypes
of Vibrio cholerae O1, the classical biotype has been
responsible for the ﬁfth and sixth cholera pandemics,
which were recorded during 1881–1896 and 1899–
1923, respectively, while the El Tor biotype is
responsible to the seventh pandemic which started
in 1961 from Celebes (currently Sulawesi), Indonesia
and is still ongoing. One of the characteristics of these
two biotypes is that each biotype has unique gene
sequences for cholera toxin B subunit (CTB), that is,
classical ctxB and El Tor ctxB.
Nair et al.49) in 2006 in Bangladesh isolated
strains that possess phenotypic El Tor biotype with
classical ctxB. For this new type of strains of V.
cholerae O1, we have recently proposed the desig-
nation of El Tor variants.50) Subsequent to the
isolation of El Tor variant in Bangladesh,49) El Tor
variant strains were isolated from several countries
and areas in Asia and Africa.51)–54) In Kolkata, India,
we also found that all V. cholerae O1 isolated were El
Tor variant.55) Moreover, as shown in Fig. 5, El Tor
variant appeared in 1990 and a complete replacement
of prototype El Tor strains by El Tor variant strains
occurred since 1995.55)
It has been known that clinical manifestation of
cholera caused by classical strains is more severe than
that caused by prototype El Tor strains. This
phenomenon has been hypothetically explained due
to a signiﬁcant diﬀerence between the amounts of
CT produced by these two biotype strains, that
is, classical strains produce much more CT than
prototype El Tor strains. Recently World Health
Organization56) reported that V. cholerae El Tor
variant causes more severe episodes of cholera with
Vibrio cholerae
O1
O2−O138
&
O140−O206
O139 Bengal
Inaba
Ogawa
Hikojima
Classical
El Tor
non−O1 non−O139
Fig. 4. Classiﬁcation of Vibrio cholerae with special reference to
O serogroup.
Y. TAKEDA [Vol. 87, 6higher case fatality rates. This report prompted us to
examine whether El Tor variant strains produce
more CT than prototype El Tor strains. As shown in
Fig. 6, it was found that the amount of CT produced
by El Tor variant strains was more or less similar
to that produced by classical strains and was much
higher than that produced by prototype El Tor
strains.57) From these data we hypothesize that
severe symptoms of cholera caused by El Tor variant
strains of V. cholerae might be due to high CT
production of the strains.
(iii) Viable but nonculturable V. cholerae.
The viable but nonculturable (VBNC) state in
bacteria is deﬁned as the bacteria remain viable but
the cells do not grow or divide on, or in, routinely
used bacteriological media. VBNC state of Vibrio
cholerae O1 was ﬁrst reported by Colwell and her
colleagues58) and this was subsequently conﬁrmed by
many groups.59)–64) In V. cholerae O1 or O139, fresh
culture of the bacteria was inoculated in a liquid of
little nutrient like buﬀers and kept at low temper-
ature in dark, cells became VBNC state. VBNC state
of V. cholerae can be easily identiﬁed morphologi-
cally, as it became a round form as shown in Fig. 7.65)
VBNC states of more than 60 species of
pathogenic and non-pathogenic bacteria have so far
been described.66) However, there has been some
skepticism on this phenomenon as a current gold
standard of bacteriology is based on culturability of
bacteria on, or in, appropriate media.
Several conditions to convert VBNC to cultur-
able state have so far been reported. These are
temperature upshift,60),67) incubation in phosphate
buﬀer,68) supplementation with H2O2-degrading com-
pounds, such as catalase or sodium pyruvate,69)
addition of heat-stable autoinducer of growth,70)
addition of resuscitation promoting factor,71) and
presence of Acanthamoeba castellanii.72) However,
there is no consensus to any of the above conditions
as the stable condition to convert VBNC to
culturable state.
Quite recently, we discovered that VBNC Vibrio
cholerae O1 and O139 were converted to the
culturable state when co-cultured with eukaryotic
cells, such as HT-29, Caco-2, T84, HeLa, and
Intestine 407 and CHO cells (Table 5).65) In early
works by Colwell’s group,73) it was demonstrated
that inoculation of VBNC V. cholerae O1 into rabbit
ileal loops resulted in ﬂuid accumulation from which
culturable V. cholerae O1 could be isolated. More-
over, it was shown that VBNC V. cholerae O1
converted to the culturable state after ingestion
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Fig. 5. Rate of classical ctxB and El Tor ctxB in Vibrio cholerae O1 strains isolated in Kolkata, India during 1989–2005 (from Ref. 55).
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Fig. 6. Amount of CT produced by various biotypes of Vibrio
cholerae O1. The amount of CT was measured by the bead-
ELISA reported by Oku et al.75) Each circle represents the
amount produced by 1 strain (from Ref. 57).
Enteric bacteria No. 1] 7during a human volunteer study.74) Our results that
showed the cultured eukaryotic cells converted
VBNC V. cholrae strains to culturable state might
have reproduced the phenomenon that Colwell and
her colleagues73),74) have demonstrated in rabbit and
human volunteers.
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